We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPCM
9301
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$4.14K ﹤0.01%
400
HCMAU
9302
DELISTED
HCM Acquisition Corp Unit
HCMAU
$4.13K ﹤0.01%
414
+110
+36% +$1.12K
IBIO icon
9303
iBio
IBIO
$69.5M
$4.13K ﹤0.01%
469
+359
+326% +$12.1K
ROCL
9304
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$4.13K ﹤0.01%
408
-1,100
-73% -$11K
BCOW
9305
DELISTED
1895 Bancorp of Wisconsin
BCOW
$4.12K ﹤0.01%
412
-300
-42% -$3.04K
MNTN.U
9306
DELISTED
Everest Consolidator Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
MNTN.U
$4.12K ﹤0.01%
407
ANEB
9307
DELISTED
Anebulo Pharmaceuticals
ANEB
$4.1K ﹤0.01%
1,696
-1,085
-39% -$2.86K
EJH icon
9308
E-Home Household Service Holdings
EJH
$4.16M
0
ABTS icon
9309
Abits Group
ABTS
$4.41M
$4.1K ﹤0.01%
607
+114
+23% +$1.44K
SABS icon
9310
SAB Biotherapeutics
SABS
$288M
$4.09K ﹤0.01%
693
+543
+362% +$4.96K
SPKB
9311
DELISTED
Silver Spike Acquisition Corp II Class A Ordinary Shares
SPKB
$4.09K ﹤0.01%
405
-200
-33% -$2K
JVA icon
9312
Coffee Holding Co
JVA
$19.9M
$4.08K ﹤0.01%
2,002
+1,702
+567% +$3.8K
SIRE
9313
DELISTED
Sisecam Resources LP
SIRE
$4.07K ﹤0.01%
194
+157
+424% +$3.42K
FRD icon
9314
Friedman Industries
FRD
$266M
$4.07K ﹤0.01%
+416
New +$3.76K
CRKN
9315
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
CORN icon
9316
Teucrium Corn Fund
CORN
$168M
$4.07K ﹤0.01%
+151
New +$4.04K
CTOR
9317
Citius Oncology
CTOR
$73M
$4.06K ﹤0.01%
+400
New +$4.05K
TUYA
9318
Tuya Inc
TUYA
$1.07B
$4.06K ﹤0.01%
+2,127
New +$2.58K
NEUP
9319
Neuphoria Therapeutics
NEUP
$21M
$4.05K ﹤0.01%
73
+62
+564% +$5.38K
ESSA
9320
DELISTED
ESSA Bancorp
ESSA
$4.05K ﹤0.01%
194
UWM icon
9321
ProShares Ultra Russell2000
UWM
$246M
$4.05K ﹤0.01%
130
-7,777
-98% -$256K
SCOBU
9322
DELISTED
ScION Tech Growth II Units
SCOBU
$4.04K ﹤0.01%
400
LVRAU
9323
DELISTED
Levere Holdings Corp. Unit
LVRAU
$4.03K ﹤0.01%
400
WPCA.U
9324
DELISTED
Warburg Pincus Capital Corporation I-A Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCA.U
$4.03K ﹤0.01%
400
+100
+33% +$999
NYC
9325
American Strategic Investment Co
NYC
$27.8M
$4.02K ﹤0.01%
284
+87
+44% +$1.87K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.